Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BA310 Abutment, BIA310 Implant/Abutment

K-Number: K182116 · 2018-12-19

Decision Date2018-12-19
Product CodeMAH
Advisory CommitteeEN
DecisionSubstantially Equivalent

Device Summary

BA310 Abutment, BIA310 Implant/Abutment is the device name listed in this FDA 510(k) record. The listed applicant is Cochlear Americas. It received FDA 510(k) clearance on 2018-12-19 under 510(k) number K182116. The device is classified under product code MAH. It was reviewed by the EN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BA310 Abutment, BIA310 Implant/Abutment?

BA310 Abutment, BIA310 Implant/Abutment is a medical device that received FDA 510(k) clearance on 2018-12-19. The listed applicant is Cochlear Americas. The 510(k) number is K182116.

When did BA310 Abutment, BIA310 Implant/Abutment receive FDA 510(k) clearance?

BA310 Abutment, BIA310 Implant/Abutment received FDA 510(k) clearance on 2018-12-19, under 510(k) number K182116.

Who is the listed applicant for BA310 Abutment, BIA310 Implant/Abutment?

The FDA 510(k) record lists Cochlear Americas as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BA310 Abutment, BIA310 Implant/Abutment?

The FDA product code for BA310 Abutment, BIA310 Implant/Abutment is MAH.

Other records listing Cochlear Americas as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 17 devices →

Related Devices (Code: MAH)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.